Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Total Liabilities (2016 - 2026)

Cryo Cell International's Total Liabilities history spans 17 years, with the latest figure at $79.3 million for Q1 2026.

  • Quarterly results put Total Liabilities at $79.3 million for Q1 2026, changed 0.31% from a year ago — trailing twelve months through Feb 2026 was $79.3 million (changed 0.31% YoY), and the annual figure for FY2025 was $80.3 million, up 3.13%.
  • Total Liabilities for Q1 2026 was $79.3 million at Cryo Cell International, down from $80.3 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $80.3 million in Q4 2025 to a low of $50.6 million in Q1 2022.
  • The 5-year median for Total Liabilities is $72.3 million (2023), against an average of $71.1 million.
  • The sharpest move saw Total Liabilities plummeted 52.73% in 2022, then skyrocketed 36.53% in 2023.
  • Year by year, Total Liabilities stood at $66.4 million in 2022, then increased by 8.79% to $72.3 million in 2023, then increased by 7.81% to $77.9 million in 2024, then rose by 3.13% to $80.3 million in 2025, then decreased by 1.31% to $79.3 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $79.3 million, $80.3 million, and $78.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.